The Manchester International Consensus Group Recommendations for the Management of Gynecological Cancers in Lynch Syndrome

Research output: Contribution to journalArticlepeer-review

Abstract

There are no internationally agreed upon clinical guidelines as to which women with gynecological cancer would benefit from Lynch syndrome screening or how best to manage the risk of gynecological cancer in women with Lynch syndrome. The Manchester International Consensus Group was convened in April 2017 to address this unmet need. The aim of the Group was to develop clear and comprehensive clinical guidance regarding the management of the gynecological sequelae of Lynch syndrome based on existing evidence and expert opinion from medical professionals and patients. Stakeholders from Europe and North America worked together over a two-day workshop to achieve consensus on best practice. Guidance was developed in four key areas: (1) whether women with gynecological cancer should be screened for Lynch syndrome and (2) how this should be done, (3) whether there was a role for gynecological surveillance in women at risk of Lynch syndrome, and (4) what preventive measures should be recommended for women with Lynch syndrome to reduce their risk of gynecological cancer. This document provides comprehensive clinical guidance that can be referenced by both patients and clinicians so that women with Lynch syndrome can expect and receive appropriate standards of care.
Original languageEnglish
JournalGenetics in Medicine
Early online date28 Mar 2019
DOIs
Publication statusPublished - 2019

Keywords

  • Lynch syndrome
  • endometrial cancer
  • guidance
  • screening
  • surveillance

Research Beacons, Institutes and Platforms

  • Manchester Cancer Research Centre

Fingerprint

Dive into the research topics of 'The Manchester International Consensus Group Recommendations for the Management of Gynecological Cancers in Lynch Syndrome'. Together they form a unique fingerprint.

Cite this